About 1 result found for searched term "TL4-12 " (0.13 seconds)
Cat.No. | Name | Target |
---|---|---|
M28703 | TL4-12 | MAPKAPK2/MAP3K/MAP4K |
TL4-12 is a selective MAP4K2/GCK inhibitor, dose-dependently downregulates IKZF1 and BCL-6 and leads to MM cell proliferation inhibition (IC50=37 nM) accompanied by induction of apoptosis. TL4-12 can be used to overcome immunomodulatory agent resistance in multiple myeloma (MM). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.